Supreme Biotechnologies, producers of AstaSupreme Astaxanthin, have launched a unique formula which combines Astaxanthin, Curcumin and Omega 3.
Supreme Biotechnologies CEO Tony Dowd says the new product is designed specifically to target inflammation in sore joints and tendons, by combining three ingredients that have been clinically validated as natural anti-inflammatory agents.
“Many people suffering from painful inflamed joints often take Astaxanthin, Curcumin and Omega 3 separately,” Dowd says. “So, we worked with a natural health consultant to combine the right quantities of each of these three ingredients, to create a powerhouse formula for painful joints.
Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 SupplementsPosted On: February 24, 2013
Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.
Solarvest has made significant progress in its plans to use its patented algal technology to develop commercial products focused on health care. The Company recently completed negotiations to acquire a 30,000 sq. ft. facility in Summerville Prince Edward Island which will be repurposed to house the Company’s planned algal production. Solarvest has acquired the facility on a lease to own basis for $436,000 with an 8-year term, the previous owner had invested in excess of $2.2 million in developing the facility.
The marine ecosystem is still an untapped reservoir of biologically active compounds, which have considerable potential to supply food ingredients towards development of new functional foods. With the goal of increasing the availability and chemical diversity of functional marine ingredients, much research has been developed using biotechnological tools to discover and produce new compounds.
This review summarizes the advances in biotechnological tools for production of functional ingredients, including enzymes, for the food industry. Tools involving biotechnological processes (bioreactors, fermentations, bioprocessing) and those involving genetic research designated as molecular biotechnology are discussed highlighting how they can be used in the controlled manipulation and utilization of marine organisms as sources of food ingredients, as well as discussing the most relevant shortcomings towards applications in new functional foods.
A new study suggests that people with early Alzheimer’s disease can be benefited by a drink containing some special nutrients.
Online edition of Journal of Alzheimer’s Disease contained this report, published on 10 July.
Alzheimer patients lose memory as the disease progresses due to the deteriorating connectivity among brain cells. Souvenaid, drink with special nutrients, can improvise this connection, said Dr. Richard Wurtman, Massachusetts Institute of Technology scientist.
Sovenaid contains three ingredients, choline, uridine and omega-3 fatty acids. Choline is B vitamin and can be found in meats, nuts and eggs. Fishes, eggs, flaxseed and meat of grass fed animals have omega-3 fatty acids. Uridine can also be gained from some food as part of RNA and it helps in making protein in the body.
These nutrients with some other essential proteins are required to make cell membranes that form synapses(connections between brain cells).
But according to William Thies, vice president for medical and scientific affairs at the Alzheimer’s Association, Souvenaid requires more research before it could go public and even then consumers need to be cautious.
We’ve all heard that eating fish is good for our brains and memory. But what is it about DHA, an omega-3 fatty acid found in fish, that makes our memory sharper?
Medical researchers at the University of Alberta have discovered a possible explanation. Their findings have been published in the peer-reviewed journal Applied Physiology, Nutrition, and Metabolism.
Principal investigator Yves Sauvé and his team discovered that lab models fed a high-DHA diet had 30 per cent higher levels of DHA in the memory section of the brain, known as the hippocampus, than lab models on a regular, healthy diet.
“We wanted to find out how fish intake improves memory,” says Sauvé, a researcher in the Faculty of Medicine & Dentistry who works in the departments of physiology and ophthalmology, and in the Centre for Neuroscience.
“What we discovered is that memory cells in the hippocampus could communicate better with each other and better relay messages when DHA levels in that region of the brain were higher. This could explain why memory improves on a high-DHA diet.”
Sauvé noted a key finding was that when a diet is supplemented with DHA, additional stores of the omega-3 fatty acid are deposited in the brain. His team confirmed this finding, a discovery other labs have noted as well.
Norway’s MareLife issues summer newsletter summarizing recent marine biotech-related activities and projectsPosted On: July 8, 2012
Marelife, the independent science-based marine innovation network, has reinforced its staff and put in operation R&D projects initiated by experienced working groups covering key areas in marine innovation. Read their new summer newsletter which sums up the Marelife activities Winter and Spring 2012.
SEE ALGAE Technology GmbH (“SAT” or the “Company”), a leading developer of infrastructure for the commercial production of high-quality algae, announced today that it had signed an agreement to supply and install a 1 hectare “dual-use” algae production plant for Recife, Brazil-based Grupo JB (“JB”), one of the leading bioethanol producers in Brazil. Once operational, this farm will primarily be utilized to produce algae biomass and bioethanol from both natural and genetically modified algae strains. Algae biomass is used as a replacement for soybean meal in feed for livestock and fish. This production process will also yield algae lipids which can be used to make biodiesel and certain biochemicals, among other compounds.
Growing International Interest In Oceanology To Benefit The Global Marine Biotechnology Market, According To New Report By Global Industry Analysts, Inc.Posted On: April 24, 2012
With growing environmental pollution throwing the spotlight on sustainable industrial development, there exists huge demand for suitable, scalable, economically, socially and environmentally sustainable feedstock options for the manufacturing industry. With sustainable feedstock production and delivery ballooning into a massive industry worldwide, the world’s oceans have emerged into the next frontier for investigative, biological resource development and management R&D projects.
For instance, marine-derived cosmetic ingredients, marine-derived molecules including enzymes, biopolymers and biomaterials, marine-derived pharmaceuticals, among others, are now becoming the mainstay of most R&D projects worldwide. The marine biotechnology sector is also attracting increased venture capital funds as is mirrored by the mushrooming of potential laden start-up firms focused on developing novel compounds from marine organisms.
As stated by the new market research report on Marine Biotechnology, Bioactive Substances represents one of the fastest growing market sectors trailing a projected CAGR of approximately 4.7% respectively.
The research report titled “Marine Biotechnology: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the marine biotechnology markets, impact of recession on the markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants.
Oil produced from shrimp could soon be used as an ingredient in food supplement products in Europe.
But since the oil is a new and novel food ingredient with no significant history of consumption in the European Union before May 15, 1997, the product, to be known by the trade name Calanus® Oil, must go through the United Kingdom’s Advisory Committee on Novel Foods and Processes (ACNFP).
An arm of the Food Standards Agency, the ACNFP is taking public comments on the Calanus® oil application until March 1, 2012Comments are considered by the committee during its assessment of the novel food ingredient.
Calanus AS of Norway is the applicant. It plans to market the oil taken from the miniature shrimp Calanus finmarchicus, one of the most common zooplankton found in the North Atlantic Ocean.